Nicotine Pharmacokinetic and Pharmacodynamics Profile, Safety and Tolerability of P3L

A Single-center, Open-label, Ascending Nicotine Levels Study to Investigate the Nicotine Pharmacokinetic and Pharmacodynamics Profiles, Safety and Tolerability of P3L in Smoking Healthy Subjects in Relation to NicoretteĀ® Inhalator


Authored by  PMI

The purpose of this study is to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD, i.e., subjective effects) profiles, and the safety and tolerability of the nicotine-containing aerosol delivered by Platform 3 Liquid (P3L) system at three different nicotine levels in smoking healthy subjects in Relation to NicoretteĀ®.

Recruitment Completed
Study Results No Results Available
Enrollment 16
Study Type Interventional
Other IDs P3L-PK-01-NZ